BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32494066)

  • 1. Landscape and function of multiple mutations within individual oncogenes.
    Saito Y; Koya J; Araki M; Kogure Y; Shingaki S; Tabata M; McClure MB; Yoshifuji K; Matsumoto S; Isaka Y; Tanaka H; Kanai T; Miyano S; Shiraishi Y; Okuno Y; Kataoka K
    Nature; 2020 Jun; 582(7810):95-99. PubMed ID: 32494066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Mutations within Individual Oncogenes: Examples and Clinical Implications.
    Kataoka K; Saito Y
    Keio J Med; 2023 Sep; 72(3):88-92. PubMed ID: 36948612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple mutations within individual oncogenes.
    Saito Y; Koya J; Kataoka K
    Cancer Sci; 2021 Feb; 112(2):483-489. PubMed ID: 33073435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase and context shape the function of composite oncogenic mutations.
    Gorelick AN; Sánchez-Rivera FJ; Cai Y; Bielski CM; Biederstedt E; Jonsson P; Richards AL; Vasan N; Penson AV; Friedman ND; Ho YJ; Baslan T; Bandlamudi C; Scaltriti M; Schultz N; Lowe SW; Reznik E; Taylor BS
    Nature; 2020 Jun; 582(7810):100-103. PubMed ID: 32461694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational landscape and significance across 12 major cancer types.
    Kandoth C; McLellan MD; Vandin F; Ye K; Niu B; Lu C; Xie M; Zhang Q; McMichael JF; Wyczalkowski MA; Leiserson MDM; Miller CA; Welch JS; Walter MJ; Wendl MC; Ley TJ; Wilson RK; Raphael BJ; Ding L
    Nature; 2013 Oct; 502(7471):333-339. PubMed ID: 24132290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
    Porta-Pardo E; Valencia A; Godzik A
    FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activating Mutations in
    Shin MK; Payne S; Bilger A; Matkowskyj KA; Carchman E; Meyer DS; Bentires-Alj M; Deming DA; Lambert PF
    Clin Cancer Res; 2019 Mar; 25(6):1889-1900. PubMed ID: 30530704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACB-PCR Quantification of Low-Frequency Hotspot Cancer-Driver Mutations.
    Myers MB; McKim KL; Wang Y; Banda M; Parsons BL
    Methods Mol Biol; 2020; 2102():395-417. PubMed ID: 31989569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double
    Vasan N; Razavi P; Johnson JL; Shao H; Shah H; Antoine A; Ladewig E; Gorelick A; Lin TY; Toska E; Xu G; Kazmi A; Chang MT; Taylor BS; Dickler MN; Jhaveri K; Chandarlapaty S; Rabadan R; Reznik E; Smith ML; Sebra R; Schimmoller F; Wilson TR; Friedman LS; Cantley LC; Scaltriti M; Baselga J
    Science; 2019 Nov; 366(6466):714-723. PubMed ID: 31699932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
    Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
    Gene; 2019 May; 697():57-66. PubMed ID: 30796966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characteristics of somatic mutations in the normal tissues of patients with cancer and existence of somatic mutant clones linked to cancer development.
    Oh JH; Sung CO
    J Med Genet; 2021 Jul; 58(7):433-441. PubMed ID: 32719100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of cancer genes and mutational processes in breast cancer.
    Stephens PJ; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; ; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR
    Nature; 2012 May; 486(7403):400-4. PubMed ID: 22722201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational patterns in oncogenes and tumour suppressors.
    Baeissa HM; Benstead-Hume G; Richardson CJ; Pearl FM
    Biochem Soc Trans; 2016 Jun; 44(3):925-31. PubMed ID: 27284061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated histone mutation H2BG53D disrupts DNA-histone octamer interaction and promotes oncogenic phenotypes.
    Wan YCE; Leung TCS; Ding D; Sun X; Liu J; Zhu L; Kang TZE; Yang D; Zhang Y; Zhang J; Qian C; Huen MSY; Li Q; Chow MZY; Zheng Z; Han J; Goel A; Wang X; Ishibashi T; Chan KM
    Signal Transduct Target Ther; 2020 Mar; 5(1):27. PubMed ID: 32296031
    [No Abstract]   [Full Text] [Related]  

  • 15. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
    Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
    BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
    Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
    Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
    Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
    Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational landscape of pan-cancer patients with PIK3CA alterations in Chinese population.
    Huang Q; Zhou Y; Wang B; Zhao Y; Zhang F; Ding B
    BMC Med Genomics; 2022 Jul; 15(1):146. PubMed ID: 35778737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
    Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
    J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.